Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.02. | Toleranzia AB: Toleranzia's clinical trial application (CTA) for TOL2 approved in Sweden | 24 | GlobeNewswire (Europe) | Toleranzia AB (the "Company" or "Toleranzia") today announces that the CTA, filed with the European Medicines Agency (EMA) for a clinical trial of the Company's investigational drug TOL2 in patients... ► Artikel lesen | |
08.02. | Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting | 134 | GlobeNewswire (Europe) | TARRYTOWN, N.Y., Feb. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first presentation of positive results from the Phase 3 QUASAR trial investigating... ► Artikel lesen | |
08.02. | Regeneron Pharmaceuticals, Inc.: Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with ... | 102 | GlobeNewswire (Europe) | At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of just twice a year: 77%... ► Artikel lesen | |
08.02. | 4D Molecular Therapeutics, Inc.: 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program | 84 | GlobeNewswire (Europe) | 3E10 vg/eye achieved an 83% reduction in injection burden vs. projected on-label aflibercept 2 mg Q8W, 70% required 0-1 supplemental injection, and 57% were injection-free through 52 weeksIn the recently... ► Artikel lesen | |
08.02. | Matthews International Corporation: Matthews International Issues Statement Following ISS Report | 667 | GlobeNewswire (Europe) | PITTSBURGH, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) ("Matthews" or the "Company") issued the following statement regarding a February 6, 2025 report... ► Artikel lesen | |
08.02. | Slovenian Tourist Board: A Borderless Celebration: Nova Gorica and Gorizia Open the European Capital of Culture | 623 | GlobeNewswire (Europe) | Slovenian Nova Gorica and Italian Gorizia are coming together to write a new cultural chapter - one without borders. On 8 February 2025, Slovenia's Cultural Holiday, the twin cities are hosting a spectacular... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
RHEINMETALL | 5.400 |
RENK GROUP | 4.036 |
NVIDIA | 3.542 |
THYSSENKRUPP | 2.826 |
HENSOLDT | 2.547 |
BYD | 2.479 |
BAYER | 2.138 |
SUPER MICRO COMPUTER | 1.498 |
TESLA | 1.480 |
TUI | 1.187 |
PALANTIR TECHNOLOGIES | 952 |
XIAOMI | 931 |
COMMERZBANK | 881 |
VOLKSWAGEN | 880 |
EVOTEC | 791 |
AIXTRON SE | 778 |
BASF | 778 |
DEUTSCHE TELEKOM | 777 |
MICROSTRATEGY | 759 |
NEL | 740 |
DEUTSCHE BANK | 732 |
ALLIANZ | 705 |
MERCEDES-BENZ | 657 |
NORDEX | 606 |
LEONARDO | 599 |